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Abstract 
Cancer is a disease that stems from genomic errors that are not corrected properly by cellular 
repair mechanisms. Errors are more likely to form when organisms are subjected to DNA 
damage by mutagenic compounds. 1-Nitropyrene, a nitrated polycyclic aromatic hydrocarbon 
(nitro-PAH), has been shown to be a potent mutagen that causes cancer. Nitro-PAHs can arise 
from diesel exhaust products in the environment. Out of all nitro-PAHs, 1-nitropyrene is found in 
largest quantities in the environment. This poses a great need to study its effects biochemically in 
order to address its toxicity in DNA. Other nitropyrene derivatives, including 1,6-dinitropyrene 
and 1,8-dinitropyrene, are known to be much more carcinogenic than 1-nitropyrene itself. 1-
Nitropyrene reacts with DNA and forms two 2’-deoxyguanosine (dG)-N2 adducts: dG-N2-6-
aminopyrene and dG-N2-8-aminopyrene. These adducts retain the same conformations as 1,6-
dinitropyrene and 1,8-dinitropyrene, respectively. This study assesses each adduct’s toxicity in 
AB1157 Escherichia coli cells. It was found that dG-N2-6-aminopyrene and dG-N2-8-
aminopyrene both have negative effects on bacterial cell viability. However, dG-N2-6-
aminopyrene was found to be more toxic than dG-N2-8-aminopyrene. 
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1. Introduction 
1.1 Carcinogenesis 
Cancer is a devastating disease and is a major public health concern worldwide. In fact, it is 
currently the second leading cause of death in the United States.1 Cancer onset is initiated by 
genetics or external stressors found within the environment.2 These two components are 
intricately analyzed in oncology in order to determine how carcinogenesis starts molecularly. 
 It has been found that the environment plays a significant role in carcinogenesis. 
Exposure to both man-made and natural substances in the environment accounts for at least two-
thirds of cancer cases in the United States.3 Carcinogens can arise from cigarette smoke, the 
consumption of alcohol or even too much sun exposure.4 These substances ultimately lead to the 
development of acquired errors in DNA. These errors are also known as mutations. Acquired 
mutations can detrimentally affect the cell cycle of somatic cells if protein synthesis is negatively 
impacted, which may lead to the formation of cancer.5 
1.2 DNA and Repair Mechanisms 
The basis of all life starts with DNA and its particular sequence of nitrogenous bases. DNA 
determines vital information needed to build and maintain an organism. Our cells require this 
information in order to proliferate and carry out specific functions.6 Sometimes DNA can be 
altered within the cell. Humans have between 20,000 and 25,000 genes.7 With so much DNA, it 
is possible for replication proteins to make mistakes in DNA synthesis. One example of a 
mistake is when a base in an original DNA sequence is replaced with an incorrect base. Every 
time cell division occurs with changed sequences, mutations can build up. If the information is 
altered constantly and mutations accumulate without repair, these mutations can negatively 
impact normal cellular functions.8 
 6 
Successful Repair Failure 
 It should be noted that mutations happen in our cells constantly.8 Cells have enzymes and 
genes that can detect these DNA errors and repair them. For example, enzymes called 
polymerases participate in repair mechanisms that identify mismatched bases and correct them. 
Their functions are of great interest in oncologic research and are commonly studied in various 
types of cells. If repair mechanisms by polymerases are not successful, cells will undergo cycle 
failure.9 
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Figure 1. Agents of DNA damage, polymerase repair mechanisms and possible outcomes.9 
 
1.3 Nitrated Polycyclic Aromatic Hydrocarbons (Nitro-PAHs) 
One class of chemical carcinogens that is commonly found in the environment is the nitro-PAHs. 
These compounds are derivatives of PAHs with at least one nitro-functional group on one of two or 
more fused aromatic rings.10,12 They are either formed from their parent PAHs by atmospheric  
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reactions or are directly emitted from diesel and gasoline engines.11 When nitro-PAHs are 
emitted into the air, they can enter the body through the lungs or skin. They tend to be stored in 
fatty tissues but usually exit the body within a few days.13 
 
Figure 2. A selection of nitro-PAHs with their parent PAHs: phenanthrene [11], 9-nitro-
phenanthrene [12], fluoranthene [13], 2-nitrofluoranthene [14], 3,9-dinitrofluoranthene 
[15], pyrene [16], 1-nitropyrene [17], 1,3-dinitropyrene [18], 1,6-dinitropyrene [19], 1,8-
dinitropyrene [20], chrysene [21], 6-nitrochrysene [22], benzo[a]pyrene [23], 6-
nitrobenzo[a]pyrene [24], 3,6-dinitrobenzo[a]pyrene [25].10 
 
Nitro-PAHs are widely studied because they are known to exhibit more toxic 
characteristics than their parent PAHs.11 In fact, their toxic properties have been analyzed and 
assigned toxicity equivalency factors (TEFs) much larger than their related PAHs. They have 
been proven to induce DNA damage, the formation of DNA adducts, changes in gene and 
protein expression, cell cycle alternations and more.10 Some of the most abundant nitro-PAHs 
found in diesel particulate matter include 1-nitropyrene, 3-nitrobenzo[e]pyrene, 7-
nitrobenz[a]anthracene, 3-nitrofluoranthene, 9-nitroanthracene and three dinitropyrene isomers 
(1,3-dinitropyrene, 1,6-dinitropyrene and 1,8-dinitropyrene).14 
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1.4 Nitropyrene Compounds 
Nitropyrene compounds are considered types of nitro-PAHs. Many nitropyrene derivatives are 
frequently studied because of their carcinogenic effects. The major derivatives of nitropyrene 
found in the environment include 1-nitropyrene, 2-nitropyrene, 4-nitropyrene, 1,3-dinitropyrene, 
1,6-dinitropyrene and 1,8-dinitropyrene (Figure 3).15 
 
Figure 3. Major nitropyrene derivatives. 
 
1-Nitropyrene is found in alarmingly higher concentrations in diesel particulate matter 
compared to the other abundant nitro-PAHs (16.4 +/- .1 µg/g vs. the next highest compound 3-
nitrobenzo[e]pyrene 2.2 +/- .2 µg/g).14 1-Nitropyrene specifically has also been detected in urban 
air particulates, certain grilled foods, and emissions from wood stoves, fire places, gas burners 
and kerosene heaters. Its toxicity is evident in its ability to act as a potent mutagen in both 
mammalian and bacterial systems.16 
The fact that 1-nitropyrene is so toxic is attractive to scientists to study its role in cancer 
onset. On the other hand, there is evidence that other nitropyrenes may have more harmful 
effects on human health. 1,6-Dinitropyrene has been shown to be more mutagenic and 
carcinogenic than 1-nitropyrene even though it is present in smaller quantities in diesel exhaust.17 
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In a past study that tested the tumorigenic abilities of both 1-nitropyrene and 1,6-dinitropyrene, 
1,6-dinitropyrene was shown to be much more tumorigenic in equimolar doses. The compound 
induced malignant fibrous histiocytomas, leukemias and mammary gland tumors.17 Additionally, 
1,8-dinitropyrene was shown to be mutagenic for mouse lymphoma L5178Y cells because it 
induced resistance to certain cancer drugs.18 
1.5 DNA Adducts 
As mentioned previously, carcinogenesis depends on the development of DNA mutations. The 
reason why nitropyrenes are so mutagenic manifests in their ability to form adducts within DNA. 
Via xanthine oxidase-catalyzed nitroreduction of 1-nitropyrene, one adduct previously identified 
as N-(deoxyguanosin-8-yl)-1-aminopyrene (C8-dG-AP) was shown to form in both mammalian 
and bacterial cells.16 Scientists later discovered that there are two additional DNA adducts that 
form via enzymatic and chemical nitroreduction of 1-nitropyrene with calf thymus DNA. The 
two found were deoxyguanosine (dG) -N2 adducts (dG-N2-6-aminopyrene and dG-N2-8-
aminopyrene or dG-N2-6-AP and dG-N2-8-AP, respectively).16 
 
Figure 4. Basic schema of 1-nitropyrene nitroreduction. N-Hydroxy-1-aminopyrene and 1-
aminopyrene can be modified further to form compounds that react directly with DNA bases.15,19 
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 dG-N2-6-AP and dG-N2-8-AP have different conformations that are derived from 1,6-
dinitropyrene and 1,8-dinitropyrene, respectively. Their reaction with guanine is influenced by 
the regioselectivity of guanine with respect to the substituted amino group.20 These variations 
may influence the level of toxicity prevalent in each adduct. 
 
Figure 5. Structures of discovered 1-nitropyrene adducts.15 
 
2. Materials 
All reagents, solvents, equipment and enzymes used were purchased from Thermo Fisher 
Scientific (Agawam, MA), Sigma-Aldrich (St. Louis, MO) and NEB (Ipswich, MA). 
Unmodified oligonucleotides were ordered from Integrated DNA Technologies (Coralville, IA). 
The 12-mer oligonucleotides containing the dG-N2-AP adducts were synthesized by C. Malik 
(University of Connecticut, Storrs CT). They reacted at G* of sequence 5’-GTGCG*TGTTTGT-
3’. The oligomers were purified using 20% denaturing polyacrylamide gel electrophoresis 
(PAGE) by C. Surugihalli. The plasmid used for study (pMS2) was gifted by M. Moriya (SUNY, 
Stony Brook NY). Finally, [γ-32P] ATP was ordered from Perkin Elmer (Waltham, MA). 
C8-dG-AP dG-N2-8-AP dG-N2-6-AP 
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3. Methods 
3.1 Purity Check of Oligonucleotides 
Oligonucleotides with site-specific lesions (1,6 dG and 1,8 dG) at G* of p53 gene sequence 5’-
GTGCG*TGTTTGT-3’, as well as an unmodified control, were checked for purity. Purity was 
assessed by PAGE using [γ-32P] ATP. The oligomers were run in excess, were labeled at 5’ and 
ran on the gel with dye at 2500 V for 6 hours at room temperature. The image was seen through 
autoradiography. Oligomer concentrations were confirmed by NanoDrop. 
3.2 pMS2 Preparation 
pMS2 is a plasmid with 5137 DNA base pairs. It has both bacterial (fl) and mammalian (SV40) 
origins of replication. It also has antibiotic resistance genes for ampicillin (AmpR) and neomycin 
(NeoR) (Figure 6).15 The multiple cloning site (MCS) has a hairpin loop with a restriction site for 
restriction endonuclease EcoRV. EcoRV cleaves at * of the sequence 5’…GAT*ATC…3’ and 
creates blunt ends (Figure 7).21 
 
 
 
 
 
 
Figure 6. pMS2 with origins of replication, antibiotic resistance genes and a multiple cloning 
site specific for EcoRV. 
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Figure 7. Hairpin loop within the MCS of pMS2, which contains a restriction site for EcoRV. 
 
 Fifty ng of pMS2 (double stranded replicative form) was carefully mixed with 50 μL of 
electro-competent E. coli DH12S cells. The mixture was transferred to an ice-cold 1-mm gapped 
electroporation cuvette. Electroporation was done at 1.8 kV with a resistance of 200 Ω and 25 μF 
charge, which was quickly followed by the addition of 1 mL pre-warmed (37°C) SOC media. 
Contents were transferred to a 14 mL Falcon® tube and were incubated at 37°C in a shaker at 
230 rpm for 1 hour. The bacterial culture was then made into 2 dilutions (1:100 and 1:50) using 
200 μL of 1X YT media for each. Each dilution was spread onto pre-warmed (37°C) 1X YT with 
ampicillin (100 μg/mL) plates, and cultures were grown overnight in a sterile incubator at 37°C.  
Approximately 100 colonies were scraped from each plate the next day using a sterile 
loop. Each dilution was individually scraped and inoculated into separate sterile 2 L flasks 
containing 400 mL of 2X YT liquid media aseptically. 1 mL of M13K07 helper phage was also 
pipetted into each flask. Each mixture was incubated at 37°C in a shaker at 250 rpm for 2 hours. 
After this incubation, 100 μg/mL of kanamycin was added to each flask. Each mixture incubated 
overnight in a shaker at the same conditions. 
The cultures were transferred into sterile 250 mL centrifuge bottles and were spun at 
10000 rpm for 15 minutes at 4°C. Supernatant was taken and transferred into another set of 
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sterile 250 mL bottles and spun again at the same conditions. The supernatant was then 
transferred to an ice-cold, sterile 2 L flask containing 4% (w/v) polyethylene glycol (PEG 8000) 
and 2.5 M NaCl. The mixture was stirred in an ice-bath for 2 hours, and the resulting solution 
was transferred into another sterile set of 250 mL centrifuge bottles. Centrifugation occurred at 
10000 rpm for 30 minutes at 4°C in order to precipitate out the DNA. Supernatant was discarded, 
and the pellets were re-suspended in 6 mL of 1X Tris-EDTA (pH 7.6) buffer. The resulting 
mixtures were aliquoted into 2 mL centrifuge tubes and were centrifuged at 10000 rpm for 10 
minutes at room temperature in order to remove insoluble PEG. The supernatant was then 
collected and transferred into a 14 mL Falcon® tube. To remove possible protein impurities, the 
supernatant was mixed with 200 μL of 10X TE (pH 8), 500 μL of 10% SDS, 156 μL of 20 
mg/mL Proteinase K and 144 μL of sterile deionized water. These added volumes are dependent 
on the supernatant volume, which was 4 mL. The tube was incubated at 42°C for 16 hours. 
The last day of preparation consisted of additional purification steps at room temperature. 
Extractions were carried out with phenol-chloroform-ISA (1:1) until the solution became clear. 
Each extraction required a 20-minute centrifugation at 14000 rpm. An additional extraction was 
done with chloroform-ISA (24:1) once. Centrifugation was for 10 minutes at 14000 rpm. 
Purification was completed with Amicon®-100 K columns. Columns were first filled with pMS2 
mixture and centrifuged at 14000 rpm for 2 minutes. 2 sterile deionized water washes followed. 
350 μL of water was added to each column prior to each wash, and centrifugation occurred under 
the same conditions. The contents in the columns were collected in 1 vial by centrifuging at 
14000 rpm for 1 minute. The plasmid was confirmed by 1.1% agarose gel, and its concentration 
was quantified using UV. Various volumes of plasmid were run to see which volume was best 
for visualization. 
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3.2 pMS2 Construct Preparation 
Preparation is briefly summarized by Figure 8. 5 μg of single-stranded pMS2 (sspMS2) was first 
incubated with 2.5 μL of 10X CutSmart® Buffer at 37°C for 1 hour. The solution was 
centrifuged at room temperature at 14000 rpm for 10 minutes. The supernatant was next digested 
with restriction endonuclease EcoRV. This was done by adding 18.8 μL of sterile deionized 
water and 1.7 μL of the enzyme together. This entire procedure was done twice more in order to 
fill 3 mini centrifuge tubes (total volume = 25 μL in each). The reaction occurred in a 37°C water 
bath for 14 hours. The cuts were confirmed by agarose gel electrophoresis. 2 μL of each reaction 
mixture and 2 μL of uncut pMS2 (control) were used to run on a 1.1% agarose gel. 
 In order for the aminopyrene adducts to be properly inserted inside the pMS2, a scaffold 
is required to facilitate insertion. A 58-mer oligonucleotide scaffold, which is complementary to 
each 12-mer lesioned sequence, was annealed to the linear pMS2. This was done by combining 
each cut plasmid with 1 μL of complimentary scaffold, 2.3 μL of 1 M NaCl, and 1 μL of sterile 
deionized water. The mixtures were heated to 80°C and then were cooled gradually to room 
temperature overnight. The next day, the plasmids were kept at 4°C for at least 12 hours. The 
scaffolded products were run on another 1.1% agarose gel along with cut pMS2 (control) for 
quantification. This was done by comparing net intensities with the control under UV light. 
 Unmodified and aminopyrene modified 12-mer inserts were then phosphorylated at the 5’ 
end. This was done by mixing each insert separately with 2.5 μL of 10X Ligase buffer, 2.5 μL of 
T4 Polynucleotide Kinase and varying volumes of sterile deionized water that depended on the 
volume of the insert (total volume = 25 μL). Phosphorylation occurred at 37°C for 1 hour. Inserts 
were later ligated to the scaffolded pMS2. Each insert was combined with scaffolded plasmid, 
7.6 μL of 10X Ligase buffer, 11.4 μL of sterile deionized water and 5 μL of T4 DNA Ligase. 
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Ligation occurred at 16°C for 18 hours. Excess ligase (1 μL) was added to each after the 18 
hours to ensure complete ligation, and the constructs were prepared for de-scaffolding after 
another 8 hours at 16°C. 
 The annealed scaffold was removed by adding 15.2 μL of 10X NEBuffer, 52.8 μL of 
sterile deionized water, 5 μL of Uracil DNA Glycosylase and 1 μL of Exonuclease-III to each 
mixture. De-scaffolding occurred at 16°C for 17 hours. The constructs were extracted by passing 
each mixture through 100 KDa centrifuge columns (Amicon®-100 K columns). This procedure 
is the same as the one depicted in plasmid preparation. The final sspMS2 constructs were again 
quantified using a 1.1% agarose gel. 
 
Figure 8. Diagram of pMS2 construct preparation. X represents the added aminopyrene inserts. 
This was also followed for preparing the unmodified control construct. 
 
3.3 Preparation of Electro-competent AB1157 E. coli Cells  
In order to assess the toxicity of the dG-N2 adducts, electro-competent E. coli cells were prepared 
and used as bacterial expression systems. It is said that life evolved from single-celled 
organisms. They possess simple biochemical processes that are very similar to processes in 
eukaryotic cells. Thus, studying the effects of the adducts in E. coli can provide beneficial data 
for future studies with mammalian cells. 
 An AB1157 E. coli cell stock was made electro-competent in a 3-day procedure. First, 
cells from the stock were streaked on a 1X LB plate in order to isolate single colonies. The plate 
EcoRV-
digestion & 
scaffolding  
Ligate oligo & 
remove scaffold 
Replicate in E. 
coli and 
analyze 
progeny 
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was incubated in a sterile incubator at 37°C overnight. On the second day, 10 mL of sterilized 
1X LB liquid media was poured into a 50 mL Falcon® tube using aseptic technique. 1 isolated 
single colony was inoculated into the media and was incubated in a shaker at 37°C for 16 hours 
at 230 rpm. 
 After 16 hours, 4 mL of the overnight culture was transferred aseptically into a 2 L flask 
containing 200 mL of 1X LB. The culture was allowed to grow for 2 additional hours at 37°C 
and 230 rpm. The flask was then moved to an ice-bath for 15 minutes, and the media was 
transferred into ice-cold 250 mL centrifuge bottles. Centrifugation occurred at 0°C for 17 
minutes at 5000 rpm. The supernatant was decanted, and 10 mL of sterile deionized water was 
added to each pellet for washing. The pellets were re-suspended and again centrifuged at the 
same conditions. Supernatant was decanted again, and a second washing occurred under the 
same conditions except 5 mL of sterile deionized water was added to each pellet. Lastly, 200 μL 
of 10% glycerol was added to 1 pellet, re-suspended, and was distributed among the other 
pellets. After each pellet was re-suspended, cells were aliquoted into multiple ice-cold microfuge 
tubes. The tubes that were not used for toxicity analysis were stored at -80°C for future use. 
3.4 Toxicity Analysis 
75 ng of both modified (1,6 dG and 1,8 dG aminopyrene) and unmodified lesions were 
individually electroporated into 50 μL of ice-cold electro-competent AB1157 E. coli cells. The 
same conditions for electroporation for pMS2 preparation were followed. After incubation, 
colonies of each type of lesion were counted. To measure the toxicity of each adduct, modified 
lesions were compared to unmodified controls. This data was expressed as a percentage: 
# 𝑜𝑓 𝑑𝐺 𝐴𝑃 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠
# 𝑜𝑓 𝐶𝑇 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠
x 100 
4. Results 
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4.1 PAGE Purification Assessment 
12-mer oligonucleotides were checked for purity and selected for further experimentation based 
on results. Any bands below the weight of the oligonucleotides (bold bands) were considered 
impurities, and oligonucleotides that presented with these bands were not used. A slight increase 
in weight presented by the modified oligomers compared to unmodified controls was noted. This 
is due to the bulkiness of the aminopyrene adducts. 
 
Figure 9. Polyacrylamide gel image of [γ-32P] ATP-labeled oligonucleotides. Lanes with X’s were 
not used for further study.  
 
4.2 Preparation of sspMS2 
After preparation, the plasmid was confirmed by 1.1% agarose gel, and the concentration was 
quantified to proceed with construct preparation. Figure 10 shows the image of the gel. The 
circular sspMS2 obtained is represented as a single band in the box by UV light.  
 
CT 1,6 1,8 1,8 1,8 CT 1,8 
x     x  
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Figure 10. Agarose gel image (1.1%) of collected pMS2 with controls. Lane 1: Freshly obtained 
circular sspMS2, Lanes 2*, 3+4: Old control sspMS2.  
* = Lane 2 had un-pure plasmid, which was apparent by the bright bands above the plasmid band. 
 
4.3 Preparation of Construct 
Gel images were taken after each main step of preparation. The EcoRV cut was confirmed by 
Figure 11, and the images of modified and unmodified lesions after de-scaffolding proved that 
the overall preparation was successful (Figures 12 and 13).  
 
Figure 11. Agarose gel image (1.1%) of restriction enzyme EcoRV cut. Lane 1: Circular pMS2 
(control), Lanes 2, 3+4: Linear sspMS2. 
1      2      3      4 
1     2      3     4 
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4.4 Toxicity Results 
75 ng of adducted and control constructs were electroporated with prepared AB1157 E. coli 
cells. The difference in cell count between lesion-containing and control colonies represents 
adduct toxicity, which is also expressed as a percentage. The lower the percentage, the more 
toxic the lesion can be considered.  
 It should be noted that the experiment with dG-N2-6-AP produced much more colonies 
than with dG-N2-8-AP. This may be because dG-N2-6-AP was done right after AB1157 cell 
preparation, whereas dG-N2-8-AP was done 3 weeks later. The time difference did not negatively 
impact transfection efficiencies, for time constants did not differ significantly (4.5-5.0). 
Figure 12. Agarose gel image (1.1%) of final de-scaffolded 
products. Lane 1: pMS2 (control), Lane 2: Unmodified 
construct, Lane 3: Modified construct containing dG-N2-6-
AP. 
1       2       3 
Figure 13. Agarose gel image (1.1%) of final de-scaffolded 
products. Lane 1: pMS2 (control), Lane 2: Unmodified 
construct, Lane 3: Modified construct containing dG-N2-8-
AP. 
1       2       3 
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Adduct 
# of Counted 
Colonies 
 
Total Colony Count 
 
Toxicity % 
Trial 1 Trial 2 
CT 9558 8645 18203  
39% 
dG-N2-6-AP 3943 3121 7064 
 
Table 1: Toxicity results of AB1157 E. coli cells with dG-N2-6-AP. 
 
 
Adduct 
# of Counted 
Colonies 
 
Total Colony Count 
 
Toxicity % 
Trial 1 Trial 2 
CT 2506 2417 4923  
60% 
dG-N2-8-AP 1612 1357 2969 
 
Table 2: Toxicity results of AB1157 E. coli cells with dG-N2-8-AP. 
 
 
Figure 14: Graph of Toxicity Percentages Among Modified Adducts. 
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5. Conclusion and Discussion 
The objective of this project was to address the toxicities of two adducts formed by 1-
nitropyrene: dG-N2-6-AP and dG-N2-8-AP. These adducts were shown to be detrimental to the 
survivability of AB1157 E. coli cells after transfection by electroporation when compared to 
unmodified control cells. The calculated toxicity percentage of dG-N2-6-AP was much less than 
the percentage of dG-N2-8-AP (39% vs. 60%), which demonstrates that dG-N2-6-AP has a higher 
toxic effect on the viability of bacterial cells. 
 This study is just a snippet of what can be researched further. It is possible to analyze 
what happens to bacterial DNA biochemically and discover what causes modified cells to 
undergo apoptosis. Thus, cells can be sequenced in order to discover any modifications that may 
have occurred in the p53 sequence. Modifications will indicate the presence of mutations that 
formed by the adducts. Future studies are also required to elucidate DNA repair mechanisms and 
to discover why mutations may exist. This research may be applied to mammalian systems in 
order to provide more data that can be beneficial for the future of human health and the 
environment. 
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